Pharmacokinetics of firocoxib after intravenous administration of multiple consecutive doses in neonatal foals

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Veterinary Pharmacology and Therapeutics

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jvp.12410PMID 28456000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of oral terbinafine in adult horses

  2017cited by this paper
• Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.

  2015cited by this paper
• Efficacy of cyclo-oxygenase inhibition by two commercially available firocoxib products in horses.

  2014cited by this paper
• In vitro hepatic microsomal metabolism of meloxicam in koalas (Phascolarctos cinereus), brushtail possums (Trichosurus vulpecula), ringtail possums (Pseudocheirus peregrinus), rats (Rattus norvegicus) and dogs (Canis lupus familiaris).

  2014cited by this paper
• Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals.

  2014cited by this paper
• Detection and pharmacokinetics of three formulations of firocoxib following multiple administrations to horses.

  2014cited by this paper
• Pharmacokinetics and safety of oral administration of meloxicam to foals.

  2013cited by this paper
• An Elucidation of the Arachidonic Acid Cascade

  2012cited by this paper
• Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.

  2012cited by this paper
• Distribution of flunixin meglumine and firocoxib into aqueous humor of horses.

  2011cited by this paper
• Prostaglandins and Inflammation

  2011cited by this paper
• Higher clearance of micafungin in neonates compared with adults: role of age‐dependent micafungin serum binding

  2011cited by this paper
• Field Trial Validation of the Efficacy and Acceptability of Firocoxib, a Highly Selective Cox-2 Inhibitor, in a Group of 96 Lame Horses

  2010cited by this paper
• A mass spectrometric study on meloxicam metabolism in horses and the fungus Cunninghamella elegans, and the relevance of this microbial system as a model of drug metabolism in the horse.

  2009cited by this paper
• Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.

  2009cited by this paper
• Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.

  2008cited by this paper
• Pharmacokinetics of firocoxib after administration of multiple consecutive daily doses to horses.

  2008cited by this paper
• Suspected Immune‐Mediated Myositis in Horses

  2007cited by this paper
• Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.

  2007cited by this paper
• Cyclooxygenase (COX) inhibitors and the intestine.

  2007cited by this paper
• Suspected immune-mediated myositis in horses.

  2007cited by this paper
• Quantitative HPLC-UV method for the determination of firocoxib from horse and dog plasma.

  2007cited by this paper
• Pharmacokinetics of Meloxicam in Patients With Juvenile Rheumatoid Arthritis

  2004cited by this paper
• Plasma clearance.

  2004cited by this paper
• Analgesics for the treatment of pain in children.

  2002cited by this paper
• Human cytochrome P450 maximal activities in pediatric versus adult liver.

  2000cited by this paper
• COX-2-Specific Inhibitors – the Emergence of a New Class of Analgesic and Anti-inflammatory Drugs

  2000cited by this paper
• Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old.

  1998cited by this paper
• Pharmacokinetics of flunixin meglumine in healthy foals less than twenty-four hours old.

  1996cited by this paper
• Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.

  1993cited by this paper
• Pharmacokinetics of phenylbutazone in neonatal foals.

  1993cited by this paper
• Pharmacokinetics of and serum thromboxane suppression by flunixin meglumine in healthy foals during the first month of life.

  1993cited by this paper
• Chronic flunixin meglumine therapy in foals.

  1988cited by this paper
• An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes.

  1987cited by this paper
• Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity.

  1986cited by this paper
• Phenylbutazone toxicosis in the foal.

  1983cited by this paper

• SINGLE-DOSE, MULTIPLE-DOSE, AND THERAPEUTIC DRUG MONITORING PHARMACOKINETICS OF FIROCOXIB IN ASIAN ELEPHANTS (ELEPHAS MAXIMUS)

  2024cites this paper
• Hematological and Biochemical Effects Associated with Prolonged Administration of the NSAID Firocoxib in Adult Healthy Horses

  2024influential citation
• Comparative disposition kinetics of oral deracoxib in sheep and goats.

  2024cites this paper
• Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses

  2023cites this paper
• SERUM DISPOSITION OF A SINGLE DOSE OF ORALLY ADMINISTERED FIROCOXIB IN AFRICAN ELEPHANTS (LOXODONTA AFRICANA)

  2023cites this paper
• Pharmacokinetics of single dose administration of three increasing doses of acetaminophen per os in 1-3-month-old foals.

  2022cites this paper
• Introduction to Equine Pharmacotherapy

  2019cites this paper
• Pharmacological Regulation in the USA and Pharmacokinetics Parameters of Firocoxib, a Highly Selective Cox-2, by Pain Management in Horses.

  2019cites this paper
• Disorders of Foals

  2017cites this paper